Daxor Corporation (DXR)

Überblick Nachrichten Preisverlauf Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Daxor Corporation Stock (DXR) Company Profile

Daxor Corporation

Healthcare (1118)

212-330-8500

Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

DXR's Discussions on Twitter

Compare DXR vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DXR Daxor Corporation	11.47	67.01M	503.40K	9.17M	-604.40K	1.8109
ISRG Intuitive Surgical Inc	472.18	170.20B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	160.62	45.41B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	77.08	38.26B	10.40B	980.00M	1.61B	1.9749
RMD Resmed Inc	231.80	33.86B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	40.92	33.33B	28.43B	1.16B	1.26B	1.4457

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-05-16	Eingeleitet	Ascendiant Capital Markets	Buy

Daxor Corporation Aktie (DXR) Neueste Nachrichten

Finanzdaten der Daxor Corporation-Aktie (DXR)

Daxor Corporation (DXR)

Daxor Corporation Stock (DXR) Company Profile

Compare DXR vs ISRG, BDX, ALC, RMD, MDLN

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Daxor Corporation Aktie (DXR) Neueste Nachrichten

DXR: Direct blood volume analysis drives improved outcomes and rapid revenue growth in a vast market - TradingView

Daxor (DXR) Unveils Portable Blood Volume Analyzer at Critical C - GuruFocus

Daxor Corporation Showcases New Portable Blood Volume Analyzer - marketscreener.com

Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress - TipRanks

Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress - GlobeNewswire

Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire

Market Overview: Will Murano Global Investments Plc Equity Warrant benefit from rate cuts2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

What analyst consensus says on Daxor Corporation stockExit Point & Fast Moving Trade Plans - Naître et grandir

Layoff Watch: Is Daxor Corporation a turnaround storyGap Up & Safe Entry Trade Reports - baoquankhu1.vn

Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat

European Stocks Set for Mixed Opening Amid Geopolitical Tensions - Intellectia AI

DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget

Daxor reports 45% revenue growth, plans regulatory shift - Investing.com

Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com

Daxor (DXR) Records Strong Growth and Regulatory Changes in 2025 - GuruFocus

Daxor issues update in Letter to Shareholders - TipRanks

Daxor (DXR) Secures FDA Clearance for Advanced Blood Volume Anal - GuruFocus

Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - TradingView

7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share - marketscreener.com

Daxor Corporation Reports 2025 Fiscal Year Results: - GlobeNewswire

DXR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

FDA‑cleared BVA boosts momentum; Daxor (NASDAQ: DXR) posts NAV $9.07 and $46M operating valuation - Stock Titan

Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0% - MarketBeat

Daxor Corporation (DXR) Competitors - Meyka

Daxor (NASDAQ:DXR) vs. Addus HomeCare (NASDAQ:ADUS) Financial Survey - Defense World

EBIT per share of Daxor Corporation – NASDAQ:DXR - TradingView

Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Daxor continues strategic expansion, opens new BVA program in Tennessee - TipRanks

Daxor (DXR) Expands BVA Program to Southern Middle Tennessee - GuruFocus

Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee - The Manila Times

Gainers Report: Will LightPath Technologies Inc benefit from government policy2025 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Daxor (NYSEAMERICAN:DXR) Stock Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Is Daxor Corporation stock a safe haven assetWeekly Profit Summary & Stock Portfolio Risk Control - mfd.ru

Can Daxor Corporation stock double in next 5 yearsTrade Risk Report & Fast Entry and Exit Trade Plans - mfd.ru

Daxor to shift regulatory reporting from Investment Company Act By Investing.com - Investing.com South Africa

Winners Losers: Is Daxor Corporation a turnaround storyWeekly Earnings Recap & Reliable Price Breakout Alerts - baoquankhu1.vn

Daxor Corp reaffirms focus on blood volume analysis technology - marketscreener.com

Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology - TradingView

Daxor to transition to Securities Exchange Act of 1934 reporting company - TipRanks

Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business - The Manila Times

Daxor Corporation Announces Transition To Securities - GlobeNewswire

Daxor (NYSEAMERICAN:DXR) Stock Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat

Trading the Move, Not the Narrative: (DXR) Edition - Stock Traders Daily

Daxor (NASDAQ:DXR) Stock Price Up 0.6%Time to Buy? - MarketBeat

Contrasting Daxor (NASDAQ:DXR) and Quest Diagnostics (NYSE:DGX) - Defense World

Aug Swings: Should I invest in Daxor Corporation before earningsPortfolio Profit Report & Safe Entry Point Alerts - baoquankhu1.vn

Guidance Update: Is Daxor Corporation a turnaround storySwing Trade & Stock Timing and Entry Methods - baoquankhu1.vn

Finanzdaten der Daxor Corporation-Aktie (DXR)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie DXR